scispace - formally typeset
J

Jee Hyun Kim

Researcher at Seoul National University Bundang Hospital

Publications -  703
Citations -  12600

Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications receiving 9907 citations. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.

Papers
More filters
Journal ArticleDOI

Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.

TL;DR: Refractory patients and patients with a poor PS do not seem to benefit from ICU care, and oncologists should try to discuss palliative care and end-of-life issues in advance to avoid futile care.
Journal ArticleDOI

The early discontinuation of palliative chemotherapy in older patients with cancer.

TL;DR: Malnutrition and dependent IADL were identified as independent predictive factors for ED and were associated with shorter overall survival in older patients with cancer.
Journal ArticleDOI

Use of a Comprehensive Geriatric Assessment to Predict Short-Term Postoperative Outcome in Elderly Patients With Colorectal Cancer

TL;DR: A preoperative CGA indicating "high-risk" was associated with major postoperative complications in elderly patients who underwent surgery for colorectal cancer, and using the CGA to identify elderly colorectic-cancer patients who should be given more care during postoperative management may be clinically beneficial.
Journal ArticleDOI

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System.

TL;DR: A GR to neoadjuvant CRT is an independent predictor of good DFS and overall survival and further stratifies patients so as to estimate the risk of recurrence and survival among patients with ypStage II and III rectal cancer.